We know it is safe from the raising of dosing from 3 days to 5 after 30% of patients had gone thru active phase of trial so safety should be a given.
SI of 426, past trials showing in vitro results highly predicated in vivo results, Brilacidin actually KILLS the virus so viral load HAS to drop dramatically, and the SOC is currently near 0 (a total waste) so how could efficacy not be pronounced? It should be near 100% with Brilacidin.